Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review

INTRODUCTION: A new therapeutic class, potassium-competitive acid blockers (P-CABs), has emerged in Brazil to promote a superior antisecretory effect addressing the unmet needs related to acid-related disease management. Vonoprazan fumarate showed a good safety profile and was approved by the Brazil...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingues, Gerson, Chinzon, Decio, Moraes-Filho, Joaquim Prado P., Senra, Juliana Tosta, Perrotti, Marcos, Zaterka, Schlioma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050988/
https://www.ncbi.nlm.nih.gov/pubmed/37007753
http://dx.doi.org/10.5114/pg.2022.116673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050988/
https://www.ncbi.nlm.nih.gov/pubmed/37007753
http://dx.doi.org/10.5114/pg.2022.116673

Ejemplares similares